The efficacy and safety of GLP-1 agonists in PCOS women living with obesity in promoting weight loss and hormonal regulation: A meta-analysis of randomized controlled trials.
GLP-1 受體激動劑在肥胖多囊卵巢症候群女性中促進減重和荷爾蒙調節的療效與安全性:隨機對照試驗的統合分析。
J Diabetes Complications 2024-08-23
Effects and plasma proteomic analysis of GLP-1RA versus CPA/EE, in combination with metformin, on overweight PCOS women: a randomized controlled trial.
GLP-1RA與CPA/EE聯合二甲双胍治療超重PCOS婦女的影響和血漿蛋白質組學分析:一項隨機對照試驗。
Endocrine 2024-03-15
Effects of GLP1RAs on pregnancy rate and menstrual cyclicity in women with polycystic ovary syndrome: a meta-analysis and systematic review.
GLP1RAs對多囊卵巢綜合徵患者的懷孕率和月經周期性的影響:一項荟萃分析和系統評論。
BMC Endocr Disord 2023-11-11
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists on Body Weight and Cardiometabolic Parameters in Individuals With Obesity and Without Diabetes: A Systematic Review and Meta-Analysis.
肥胖且無糖尿病個體中胰高血糖素樣肽-1受體激動劑對體重和心臟代謝參數的功效和安全性:系統性回顧和荟萃分析。
Endocr Pract 2024-02-06
Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis.
肥胖患者 GLP-1RAs 的功效和安全性:基於 RCT 和貝葉斯網絡荟萃分析的系統性回顧。
Biomed Pharmacother 2024-02-15
Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
多囊卵巢症的抗肥胖藥物:一項系統性回顧和荟萃分析,以制定2023年國際循證指南。
Obes Rev 2024-04-18
A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
GLP-1對於多囊卵巢症患者體型、代謝和內分泌參數的系統性回顧。
Womens Health (Lond) 2024-03-08
Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s.
多囊卵巢綜合症女性的胰高血糖素分泌:肥胖、胰島素敏感性以及二甲双胍和 GLP-1s 治療的作用。
Biomedicines 2024-03-30
Efficacy and safety of glucagon-like peptide-1 receptor agonists in the treatment of polycystic ovary syndrome-A systematic review and meta-analysis.
胰高血糖素樣肽-1 受體激動劑在多囊卵巢綜合症治療中的療效與安全性—系統性回顧與統合分析。
Arch Physiol Biochem 2024-07-31
Clinical Effects of Glucagon-Like Peptide-1 Agonist Use for Weight Loss in Women With Polycystic Ovary Syndrome: A Scoping Review.
多囊卵巢症候群女性使用胰高血糖素樣肽-1激動劑減重的臨床效果:範疇回顧。
Cureus 2024-09-12